Our data showed that the expression levels of CD68 (by Rt-PCR, FCM and/or IHC) associated significantly with the poor prognostic factors of cHL patients including the decreased B cell markers (CD20) expression, and only CD68 mRNA expression associated significantly with advanced disease stage. Here, CD68 is linked to classic Hodgkin lymphoma.